Factors associated with early atherosclerosis and arterial calcifications in young subjects with a benign phenotype of obesity

Obesity

Volumn 19, Issue 8, 2011, Pages 1684-1689

  Gilardini, Luisa ^a   Pasqualinotto, Lucia ^a   Di Matteo, Silvia ^a   Caffetto, Katherine ^a   Croci, Marina ^a   Girola, Andrea ^a   Invitti, Cecilia ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; C REACTIVE PROTEIN; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; PARATHYROID HORMONE; PHOSPHORUS; PLASMINOGEN ACTIVATOR INHIBITOR 1; URIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; BODY COMPOSITION; CALCIUM BALANCE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY CALCIFICATION; CAROTID ARTERY DISEASE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FAMILY HISTORY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINERAL BALANCE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PARATHYROID HORMONE BLOOD LEVEL; PHENOTYPE; PHOSPHATE BLOOD LEVEL; PHOSPHORUS BALANCE; PROTEIN BLOOD LEVEL; PUBERTY; SCHOOL CHILD; SEX DIFFERENCE; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADIPONECTIN; ADOLESCENT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CALCIUM; CAROTID ARTERIES; CHILD; CHOLESTEROL, HDL; FAMILY; FEMALE; HUMANS; MALE; OBESITY; PARATHYROID HORMONE; PHENOTYPE; PHOSPHORUS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PUBERTY; RISK FACTORS; TUNICA INTIMA; URIC ACID; VITAMIN D;

EID: 79960835355     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.342     Document Type: Article

References (38)

1. Strong JP, Malcom GT, McMahan CA et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999;281:727-735. (Pubitemid 29113454)
2. Slyper AH. Clinical review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab 2004;89:3089-3095. (Pubitemid 38951866)
3. Beauloye V, Zech F, Tran HT et al. Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab 2007;92: 3025-3032. (Pubitemid 47236366)
4. Pilz S, Horejsi R, Möller R et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005;90:4792-4796. (Pubitemid 41159373)
5. Pacifico L, Cantisani V, Anania C et al. Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children. Eur J Endocrinol 2009;160:45-52.
6. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009;32:2297-2299.
7. Wildman RP, Muntner P, Reynolds K et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624.
8. Kip KE, Marroquin OC, Kelley DE et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004;109:706-713. (Pubitemid 38222888)
9. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-1243. (Pubitemid 30240471)
10. Genuth S, Alberti KG, Bennett P et al.; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
11. Lurbe E, Cifkova R, Cruickshank JK et al.; European Society of Hypertension. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009;27:1719-1742.
12. Cook S, Auinger P, Huang TT. Growth curves for cardio-metabolic risk factors in children and adolescents. J Pediatr 2009;155:S6.e15-S6.e26.
13. Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G. Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 2003;26:118-124. (Pubitemid 36929003)
14. van Staveren WA, de Boer JO, Burema J. Validity and reproducibility of a dietary history method estimating the usual food intake during one month. Am J Clin Nutr 1985;42:554-559. (Pubitemid 15227643)
15. Howard G, Sharrett AR, Heiss G et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993;24:1297-1304. (Pubitemid 23254630)
16. Morrison KM, Dyal L, Conner W et al. Cardiovascular risk factors and noninvasive assessment of subclinical atherosclerosis in youth. Atherosclerosis 2010;208:501-505.
17. Barra S, Gaeta G, Cuomo V et al. Parental history of premature myocardial infarction is a stronger predictor of increased carotid intima-media thickness than parental history of hypertension. Nutr Metab Cardiovasc Dis 2010; e-pub ahead of print 15 February 2010.
18. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006;55:113-118. (Pubitemid 41736256)
19. Mittelman SD, Gilsanz P, Mo AO et al. Adiposity predicts carotid intima-media thickness in healthy children and adolescents. J Pediatr 2010;156:592-7.e2.
20. Alessi MC, Poggi M, Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 2007;18:240-245. (Pubitemid 46743045)
21. Morange PE, Aubert J, Peiretti F et al. Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes 1999;48:890-895. (Pubitemid 29153091)
22. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002;51: 1131-1137. (Pubitemid 34438360)
23. Chen Y, Budd RC, Kelm RJ Jr, Sobel BE, Schneider DJ. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol 2006;26:1777-1783. (Pubitemid 44305331)
24. Fay WP, Garg N, Sunkar M. Vascular functions of the plasminogen activation system. Arterioscler Thromb Vasc Biol 2007;27:1231-1237. (Pubitemid 46809410)
25. Peng Y, Liu H, Liu F et al. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients. Nephrology (Carlton) 2008;13:579-586.
26. Sakata T, Mannami T, Baba S et al. Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries. Atherosclerosis 2004;176:355-360. (Pubitemid 39369526)
27. Livingstone MB, Prentice AM, Coward WA et al. Validation of estimates of energy intake by weighed dietary record and diet history in children and adolescents. Am J Clin Nutr 1992;56:29-35.
28. Merchant AT, Kelemen LE, de Koning L et al.; SHARE and SHARE-AP investigators. Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis. Am J Clin Nutr 2008;87:168-174.
29. He K, Liu K, Daviglus ML et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am J Clin Nutr 2008;88:1111-1118.
30. Buil-Cosiales P, Irimia P, Ros E et al. Dietary fibre intake is inversely associated with carotid intima-media thickness: a cross-sectional assessment in the PREDIMED study. Eur J Clin Nutr 2009;63:1213-1219.
31. Croymans DM, Sanchez A, Barth JD, Roberts CK. Carotid intima-media thickness, dietary intake, and cardiovascular phenotypes in adolescents: relation to metabolic syndrome. Metabolism 2010;59:533-539.
32. Micheletti RG, Fishbein GA, Currier JS, Fishbein MC. Mönckeberg sclerosis revisited: a clarification of the histologic definition of Mönckeberg sclerosis. Arch Pathol Lab Med 2008;132:43-47.
33. Lilien MR, Groothoff JW. Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol 2009;5:229-235.
34. Sanchez CP. Mineral metabolism and bone abnormalities in children with chronic renal failure. Rev Endocr Metab Disord 2008;9:131-137.
35. Snijder MB, van Dam RM, Visser M et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005;90:4119-4123. (Pubitemid 41058184)
36. Usdin TB, Bonner TI, Harta G, Mezey E. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology 1996;137:4285-4297. (Pubitemid 26321877)
37. Rashid G, Bernheim J, Green J, Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 2007;292:F1215-F1218. (Pubitemid 46572440)
38. Rashid G, Plotkin E, Klein O et al. Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C. Am J Physiol Renal Physiol 2009;296:F60-F66.